De Clercq & Partners highly recommended by IAM and the Financial Times!
Good news galore today as De Clercq & Partners has once again earned a place in the IAM Patent 1000 Guide as a Highly Recommended firm for patent prosecution in Belgium. And that's not all, because for the second year in a row, the world-renowned Financial Times has also featured us as one of Europe's leading patent firms.
IAM Patent 1000
The IAM Patent 1000 has become the definitive directory exclusively dedicated to identifying the world’s leading patent services providers. The extensive research process for this guide was conducted over several months by a team of full-time analysts, and involved more than 1,700 interviews with patent specialists across the globe. Legal and attorney firms and individual practitioners qualify for inclusion in the IAM Patent 1000 upon receiving sufficient positive feedback from market sources.
Hard work pays off as once again, De Clercq & Partners has managed to secure a place in the highest rankings of the IAM Patent 1000 Guide, labelling us as a highly recommended firm for patent prosecution in Belgium!
The guide has also published a few words of praise for our firm: “Depth of technical expertise, knowledge, attention to detail and efficient handling of instructions make De Clercq & Partners the first choice for patent prosecution work in Europe. [...] The group reliably suggests strategies that take into account the most recent legal and procedural developments at the EPO, and provides insightful, cost-effective guidance which obtains commercially meaningful patents.”
Read IAM's full commentary on De Clercq & Partners and consult the rest of the Belgian rankings via the link.
The Financial Times
Today, after extensive and thorough research, the Financial Times published their list of Europe's Leading Patent Law Firms. The list highlights the firms rated most highly by their clients and peers.
For the second year in a row, De Clercq & Partners is honored to be included as the only Belgian Patent Law Firm in two categories:
- Silver award for our endeavors in Biotechnology and Food.
- Bronze award for our work in Chemistry and Pharmaceuticals